Bone density in women receiving depot medroxyprogesterone acetate for contraception.

Abstract

Women using DMPA have bone density values intermediate between those of normal premenopausal and postmenopausal controls; thus, the degree of oestrogen deficiency induced by DMPA may have an adverse effect on bone density.